This code system http://hl7.org/fhir/sid/cvx defines many codes, of which the following are a subset:
| Code | Display | Definition | V2 Table Status | deprecated | V2 Concept Comment As Published |
| 54 | adenovirus, type 4 | adenovirus, type 4 | A | 2.9 | adenovirus vaccine, type 4, live, oral |
| 55 | adenovirus, type 7 | adenovirus, type 7 | A | 2.9 | adenovirus vaccine, type 7, live, oral |
| 82 | adenovirus, NOS1 | adenovirus, NOS1 | A | 2.9 | adenovirus vaccine, NOS |
| 24 | anthrax | anthrax | A | 2.9 | anthrax vaccine |
| 19 | BCG | BCG | A | 2.9 | Bacillus Calmette-Guerin vaccine |
| 27 | botulinum antitoxin | botulinum antitoxin | A | 2.9 | botulinum antitoxin |
| 26 | cholera | cholera | A | 2.9 | cholera vaccine |
| 29 | CMVIG | CMVIG | A | 2.9 | cytomegalovirus immune globulin, intravenous |
| 56 | dengue fever | dengue fever | A | 2.9 | dengue fever vaccine |
| 12 | diphtheria antitoxin | diphtheria antitoxin | A | 2.9 | diphtheria antitoxin |
| 28 | DT (pediatric) | DT (pediatric) | A | 2.9 | diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 20 | DTaP | DTaP | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 106 | DTaP, 5 pertussis antigens6 | DTaP, 5 pertussis antigens6 | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 | DTaP, NOS | DTaP, NOS | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, NOS |
| 110 | DTaP-Hep B-IPV | DTaP-Hep B-IPV | A | 2.9 | DTaP-hepatitis B and poliovirus vaccine |
| 50 | DTaP-Hib | DTaP-Hib | A | 2.9 | DTaP-Haemophilus influenzae type b conjugate vaccine |
| 120 | DTaP-Hib-IPV | DTaP-Hib-IPV | A | 2.9 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 01 | DTP | DTP | A | 2.9 | diphtheria, tetanus toxoids and pertussis vaccine |
| 22 | DTP-Hib | DTP-Hib | A | 2.9 | DTP-Haemophilus influenzae type b conjugate vaccine |
| 102 | DTP-Hib-Hep B | DTP-Hib-Hep B | A | 2.9 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 57 | hantavirus | hantavirus | A | 2.9 | hantavirus vaccine |
| 52 | Hep A, adult | Hep A, adult | A | 2.9 | hepatitis A vaccine, adult dosage |
| 83 | Hep A, ped/adol, 2 dose | Hep A, ped/adol, 2 dose | A | 2.9 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 | Hep A, ped/adol, 3 dose | Hep A, ped/adol, 3 dose | A | 2.9 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 31 | Hep A, pediatric, NOS | Hep A, pediatric, NOS | A | 2.9 | hepatitis A vaccine, pediatric dosage, NOS |
| 85 | Hep A, NOS | Hep A, NOS | A | 2.9 | hepatitis A vaccine, NOS |
| 104 | Hep A-Hep B | Hep A-Hep B | A | 2.9 | hepatitis A and hepatitis B vaccine |
| 30 | HBIG | HBIG | A | 2.9 | hepatitis B immune globulin |
| 08 | Hep B, adolescent or pediatric | Hep B, adolescent or pediatric | A | 2.9 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| 42 | Hep B, adolescent/high risk infant2 | Hep B, adolescent/high risk infant2 | A | 2.9 | hepatitis B vaccine, adolescent/high risk infant dosage |
| 43 | Hep B, adult4 | Hep B, adult4 | A | 2.9 | hepatitis B vaccine, adult dosage |
| 44 | Hep B, dialysis | Hep B, dialysis | A | 2.9 | hepatitis B vaccine, dialysis patient dosage |
| 45 | Hep B, NOS | Hep B, NOS | A | 2.9 | hepatitis B vaccine, NOS |
| 58 | Hep C | Hep C | A | 2.9 | hepatitis C vaccine |
| 59 | Hep E | Hep E | A | 2.9 | hepatitis E vaccine |
| 60 | herpes simplex 2 | herpes simplex 2 | A | 2.9 | herpes simplex virus, type 2 vaccine |
| 46 | Hib (PRP-D) | Hib (PRP-D) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 | Hib (HbOC) | Hib (HbOC) | A | 2.9 | Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 | Hib (PRP-T) | Hib (PRP-T) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 | Hib (PRP-OMP) | Hib (PRP-OMP) | A | 2.9 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 17 | Hib, NOS | Hib, NOS | A | 2.9 | Haemophilus influenzae type b vaccine, conjugate NOS |
| 51 | Hib-Hep B | Hib-Hep B | A | 2.9 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 61 | HIV | HIV | A | 2.9 | human immunodeficiency virus vaccine |
| 118 | HPV, bivalent | HPV, bivalent | A | 2.9 | human papilloma virus vaccine, bivalent |
| 62 | HPV, quadrivalent | HPV, quadrivalent | A | 2.9 | human papilloma virus vaccine, quadrivalent |
| 86 | IG | IG | A | 2.9 | immune globulin, intramuscular |
| 87 | IGIV | IGIV | A | 2.9 | immune globulin, intravenous |
| 14 | IG, NOS | IG, NOS | A | 2.9 | immune globulin, NOS |
| 111 | influenza, live, intranasal | influenza, live, intranasal | A | 2.9 | influenza virus vaccine, live, attenuated, for intranasal use |
| 15 | influenza, split (incl. purified surface antigen) | influenza, split (incl. purified surface antigen) | A | 2.9 | influenza virus vaccine, split virus (incl. purified surface antigen) |
| 16 | influenza, whole | influenza, whole | A | 2.9 | influenza virus vaccine, whole virus |
| 88 | influenza, NOS | influenza, NOS | A | 2.9 | influenza virus vaccine, NOS |
| 10 | IPV | IPV | A | 2.9 | poliovirus vaccine, inactivated |
| 02 | OPV | OPV | A | 2.9 | poliovirus vaccine, live, oral |
| 89 | polio, NOS | polio, NOS | A | 2.9 | poliovirus vaccine, NOS |
| 39 | Japanese encephalitis | Japanese encephalitis | A | 2.9 | Japanese encephalitis vaccine |
| 63 | Junin virus | Junin virus | A | 2.9 | Junin virus vaccine |
| 64 | leishmaniasis | leishmaniasis | A | 2.9 | leishmaniasis vaccine |
| 65 | leprosy | leprosy | A | 2.9 | leprosy vaccine |
| 66 | Lyme disease | Lyme disease | A | 2.9 | Lyme disease vaccine |
| 03 | MMR | MMR | A | 2.9 | measles, mumps and rubella virus vaccine |
| 04 | M/R | M/R | A | 2.9 | measles and rubella virus vaccine |
| 94 | MMRV | MMRV | A | 2.9 | measles, mumps, rubella, and varicella virus vaccine |
| 67 | malaria | malaria | A | 2.9 | malaria vaccine |
| 05 | measles | measles | A | 2.9 | measles virus vaccine |
| 68 | melanoma | melanoma | A | 2.9 | melanoma vaccine |
| 32 | meningococcal | meningococcal | A | 2.9 | meningococcal polysaccharide vaccine (MPSV4) |
| 103 | meningococcal C conjugate | meningococcal C conjugate | A | 2.9 | meningococcal C conjugate vaccine |
| 114 | meningococcal A,C,Y,W-135 diphtheria conjugate | meningococcal A,C,Y,W-135 diphtheria conjugate | A | 2.9 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4) |
| 108 | meningococcal, NOS | meningococcal, NOS | A | 2.9 | meningococcal vaccine, NOS |
| 07 | mumps | mumps | A | 2.9 | mumps virus vaccine |
| 69 | parainfluenza-3 | parainfluenza-3 | A | 2.9 | parainfluenza-3 virus vaccine |
| 11 | pertussis | pertussis | A | 2.9 | pertussis vaccine |
| 23 | plague | plague | A | 2.9 | plague vaccine |
| 33 | pneumococcal | pneumococcal | A | 2.9 | pneumococcal polysaccharide vaccine |
| 100 | pneumococcal conjugate | pneumococcal conjugate | A | 2.9 | pneumococcal conjugate vaccine, polyvalent |
| 109 | pneumococcal, NOS | pneumococcal, NOS | A | 2.9 | pneumococcal vaccine, NOS |
| 70 | Q fever | Q fever | A | 2.9 | Q fever vaccine |
| 18 | rabies, intramuscular injection | rabies, intramuscular injection | A | 2.9 | rabies vaccine, for intramuscular injection |
| 40 | rabies, intradermal injection | rabies, intradermal injection | A | 2.9 | rabies vaccine, for intradermal injection |
| 90 | rabies, NOS | rabies, NOS | A | 2.9 | rabies vaccine, NOS |
| 72 | rheumatic fever | rheumatic fever | A | 2.9 | rheumatic fever vaccine |
| 73 | Rift Valley fever | Rift Valley fever | A | 2.9 | Rift Valley fever vaccine |
| 34 | RIG | RIG | A | 2.9 | rabies immune globulin |
| 119 | rotavirus, monovalent | rotavirus, monovalent | A | 2.9 | rotavirus, live, monovalent vaccine |
| 122 | rotavirus, NOS1 | rotavirus, NOS1 | A | 2.9 | rotavirus vaccine, NOS |
| 116 | rotavirus, pentavalent | rotavirus, pentavalent | A | 2.9 | rotavirus, live, pentavalent vaccine |
| 74 | rotavirus, tetravalent | rotavirus, tetravalent | A | 2.9 | rotavirus, live, tetravalent vaccine |
| 71 | RSV-IGIV | RSV-IGIV | A | 2.9 | respiratory syncytial virus immune globulin, intravenous |
| 93 | RSV-MAb | RSV-MAb | A | 2.9 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 06 | rubella | rubella | A | 2.9 | rubella virus vaccine |
| 38 | rubella/mumps | rubella/mumps | A | 2.9 | rubella and mumps virus vaccine |
| 76 | Staphylococcus bacterio lysate | Staphylococcus bacterio lysate | A | 2.9 | Staphylococcus bacteriophage lysate |
| 113 | Td (adult) | Td (adult) | A | 2.9 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use |
| 09 | Td (adult) | Td (adult) | A | 2.9 | tetanus and diphtheria toxoids, adsorbed for adult use |
| 115 | Tdap | Tdap | A | 2.9 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 35 | tetanus toxoid | tetanus toxoid | A | 2.9 | tetanus toxoid, adsorbed |
| 112 | tetanus toxoid, NOS | tetanus toxoid, NOS | A | 2.9 | tetanus toxoid, NOS |
| 77 | tick-borne encephalitis | tick-borne encephalitis | A | 2.9 | tick-borne encephalitis vaccine |
| 13 | TIG | TIG | A | 2.9 | tetanus immune globulin |
| 95 | TST-OT tine test | TST-OT tine test | A | 2.9 | tuberculin skin test; old tuberculin, multipuncture device |
| 96 | TST-PPD intradermal | TST-PPD intradermal | A | 2.9 | tuberculin skin test; purified protein derivative solution, intradermal |
| 97 | TST-PPD tine test | TST-PPD tine test | A | 2.9 | tuberculin skin test; purified protein derivative, multipuncture device |
| 98 | TST, NOS | TST, NOS | A | 2.9 | tuberculin skin test; NOS |
| 78 | tularemia vaccine | tularemia vaccine | A | 2.9 | tularemia vaccine |
| 91 | typhoid, NOS | typhoid, NOS | A | 2.9 | typhoid vaccine, NOS |
| 25 | typhoid, oral | typhoid, oral | A | 2.9 | typhoid vaccine, live, oral |
| 41 | typhoid, parenteral | typhoid, parenteral | A | 2.9 | typhoid vaccine, parenteral, other than acetone-killed, dried |
| 53 | typhoid, parenteral, AKD (U.S. military) | typhoid, parenteral, AKD (U.S. military) | A | 2.9 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| 101 | typhoid, ViCPs | typhoid, ViCPs | A | 2.9 | typhoid Vi capsular polysaccharide vaccine |
| 75 | vaccinia (smallpox) | vaccinia (smallpox) | A | 2.9 | vaccinia (smallpox) vaccine |
| 105 | vaccinia (smallpox) diluted | vaccinia (smallpox) diluted | A | 2.9 | vaccinia (smallpox) vaccine, diluted |
| 79 | vaccinia immune globulin | vaccinia immune globulin | A | 2.9 | vaccinia immune globulin |
| 21 | varicella | varicella | A | 2.9 | varicella virus vaccine |
| 81 | VEE, inactivated | VEE, inactivated | A | 2.9 | Venezuelan equine encephalitis, inactivated |
| 80 | VEE, live | VEE, live | A | 2.9 | Venezuelan equine encephalitis, live, attenuated |
| 92 | VEE, NOS | VEE, NOS | A | 2.9 | Venezuelan equine encephalitis vaccine, NOS |
| 36 | VZIG | VZIG | A | 2.9 | varicella zoster immune globulin |
| 117 | VZIG (IND) | VZIG (IND) | A | 2.9 | varicella zoster immune globulin (Investigational New Drug) |
| 37 | yellow fever | yellow fever | A | 2.9 | yellow fever vaccine |
| 121 | zoster | zoster | A | 2.9 | zoster vaccine, live |
| 998 | no vaccine administered5 | no vaccine administered5 | A | 2.9 | no vaccine administered |
| 999 | unknown | unknown | A | 2.9 | unknown vaccine or immune globulin |
| 99 | RESERVED - do not use3 | RESERVED - do not use3 | A | 2.9 | RESERVED - do not use |